AAMAC Webinar - Friday May 22, 2020

[AAMAC]

Time: 10 am (Pacific Time (PT))

Speaker: Dr Heather Leitch

Topic: Brief update on Covid-19 followed by a Q&A

THE SPEAKER:

Dr. Heather Leitch, Director Hematology/Oncology Research (SPH), Clinical Professor, St. Paul’s Hospital


Dr. Heather Leitch completed a PhD in microbiology (leukemia stem cell research) at UBC in 1992. She graduated from medical school at UBC in 1995, trained in internal medicine at UBC, and completed a hematology fellowship at McGill University in 2000, where she also completed course requirements toward a master’s degree in epidemiology and biostatistics. She completed post-fellowship training with the Lymphoma Tumour Group at the B.C. Cancer Agency in 2002, and currently holds the position of Clinical Associate Professor at UBC. Dr. Leitch has been a member of the hematology/oncology group at St. Paul’s Hospital since 2004, and actively participates in research projects and clinical trials with a focus on hematological malignancies. Recent publications co-authored by Dr. Leitch have focused on the treatment of: iron overload in patients with myelodysplastic syndromes (MDS) and other acquired bone marrow failure syndromes; HIV-associated lymphoma; monoclonal B-cell lymphocytosis; and relapsed/refractory myeloma, MDS, and lymphoma.

To register email info@aamac.ca or call 1-888-840-0039

[AAMAC]

Time: 11 am (Pacific Time (PT)) (PLEASE NOTE THE TIME CHANGE)

Speaker: Dr Heather Leitch

Topic: Brief update on Covid-19 followed by a Q&A

THE SPEAKER:
Dr. Heather Leitch, Director Hematology/Oncology Research (SPH), Clinical Professor, St. Paul’s Hospital


Dr. Heather Leitch completed a PhD in microbiology (leukemia stem cell research) at UBC in 1992. She graduated from medical school at UBC in 1995, trained in internal medicine at UBC, and completed a hematology fellowship at McGill University in 2000, where she also completed course requirements toward a master’s degree in epidemiology and biostatistics. She completed post-fellowship training with the Lymphoma Tumour Group at the B.C. Cancer Agency in 2002, and currently holds the position of Clinical Associate Professor at UBC. Dr. Leitch has been a member of the hematology/oncology group at St. Paul’s Hospital since 2004, and actively participates in research projects and clinical trials with a focus on hematological malignancies. Recent publications co-authored by Dr. Leitch have focused on the treatment of: iron overload in patients with myelodysplastic syndromes (MDS) and other acquired bone marrow failure syndromes; HIV-associated lymphoma; monoclonal B-cell lymphocytosis; and relapsed/refractory myeloma, MDS, and lymphoma.

To register:

• Go to https://attendee.gotowebinar.com/reg...43501892706061; or
• email info@aamac.ca; or
• call 1-888-840-0039

[AAMAC]

TODAY'S WEBINAR HAS BEEN CANCELLED.

Unfortunately the speaker is unwell. We wish her a speedy recovery.